Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | MMP9 | P14780 | 2/20 | 0.32 |
| ▸ | MMP8 | P22894 | 2/20 | 0.32 |
| ▸ | MMP13 | P45452 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL933456 | 0.91 | THRB (0.44) | THRBTP53CA1CA2MMP1 | |
| SCHEMBL8985374 | 0.91 | THRB (0.44) | THRBTP53CA1CA2MMP1 | |
| SCHEMBL1766346 | 0.84 | TP53 (0.38) | TP53 | |
| SCHEMBL20856788 | 0.78 | THRB (0.31) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL28684999 | 0.78 | THRB (0.32) | THRB | |
| SCHEMBL28648873 | 0.74 | TP53 (0.38) | TP53 | |
| SCHEMBL19863241 | 0.73 | CES1 (0.44) | — | |
| SCHEMBL8858648 | 0.73 | THRB (0.41) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL8858644 | 0.73 | THRB (0.41) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL1032404 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2643289-B1 | PROCESS FOR PRODUCING PERFLUORINATED ORGANIC COMPOUNDS | SOLVAY SPECIALTY POLYMERS IT (IT) | 2018-01-24 | — | — | EP | disclosed |
| US-9051259-B2 | Process for producing perfluorinated organic compounds | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2015-06-09 | — | — | US | disclosed |
| EP-2643289-A1 | PROCESS FOR PRODUCING PERFLUORINATED ORGANIC COMPOUNDS | Solvay Specialty Polymers Italy S.p.A. (IT) | 2013-10-02 | — | — | EP | disclosed |
| US-20130245289-A1 | Process for producing perfluorinated organic compounds | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2013-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130245289-A1 | Process for producing perfluorinated organic compounds | PFAS, ADH1A, CYP2F1 | THRB 737/4885TP53 1651/4885CA1 1177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.